Results 251 to 251 of about 233,563 (251)

PORTEC‐3 trial finds that adjuvant chemoradiotherapy significantly improves 10‐year survival for patients with high‐risk endometrial cancer

Ca-A Cancer Journal for Clinicians
exaly